Impact of Expression and Genetic Variation of microRNA-34b/c on Cognitive Dysfunction in Patients with Major Depressive Disorder.
Ning SunChunxia YangXiaoting HeZhifen LiuSha LiuXinrong LiYanfang WangRuihua JinKerang ZhangPublished in: Neuropsychiatric disease and treatment (2020)
Our findings suggest that changes in miR-34c expression level have important impacts on cognitive function in patients with MDD. In particular, the polymorphism rs2187473 is a potential genetic risk factor for cognitive function in MDD, which may be of clinical use.